COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines

NCT04845191 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The sponsor has changed the development plans which is not for safety reasons.

Conditions

Interventions

Sponsor

ImmunityBio, Inc.